# Impact of 100mL Lipid Emulsion for Intravenous for Suppression of Myocardial Glucose Metabolism in 18F-FDG PET/CT

> **NCT04437927** · — · COMPLETED · sponsor: **Centre Hospitalier Princesse Grace** · enrollment: 51 (actual)

## Conditions studied

- Metabolic Preparation
- Myocardial Inflammation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04437927
- **Lead sponsor:** Centre Hospitalier Princesse Grace
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-07
- **Primary completion:** 2020-11-06
- **Final completion:** 2020-11-06
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2020-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04437927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04437927, "Impact of 100mL Lipid Emulsion for Intravenous for Suppression of Myocardial Glucose Metabolism in 18F-FDG PET/CT". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04437927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
